The stock of General Moly, Inc. (NYSE:GMO) is now priced at $0.14 and the shares are 0 points down or 1.39% lower compared to its previous closing price of $0.14. The stock had 2.397 million contracts set over the past session. GMO shares’ daily volume is compared to its average trading volume at 1.397 million shares. However, it has a float of 82.74 million and although its performance was 10.69% over the week, it’s one to watch. It means the stock’s downside potential is -100% with the GMO share price recently placing at $0.12 to $0.15. However, some brokerage firms have priced the stock below the average, including one that has called $0.75.

The shorts are running away from the General Moly, Inc. stock, with the latest data on short interest released on July 31, 2020, showing that short interest numbers in the GMO shares have declined. Short interest in the stock represents just 0.28% of its float, but the volume has dropped by 0.

In the last trading session, General Moly, Inc. (NYSE:GMO) raised by $0.0134 over the week and lost -$0.0814 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $0.366. The stock recorded its established 52-week high on 06/09/20.

Since 08/26/20, the stock has traded to a low of $0.1001 at 38.66%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge. The stock has a beta allocation of 0.47. Being above 1 means that the stock’s volatility is higher than the market and traders are keenly watching it.

Looking at current readings, General Moly, Inc.’s two-week RSI is 37.6. This suggests that the stock is neutral at the moment and that GMO shares’ price movement remains stable. The stochastic readings are equally revealing at 30.42% meaning the GMO share price is currently in neutral territory.

The technical chart shows that the GMO stock will likely settle at between $0.1512 and $0.1636 per share. However, if the stock dips below $0.1227, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $0.1066.

Currently, the stock is trading in the green of MACD, with a reading of 0.0001. Investors always pay attention to any move above or below the zero-line, mainly because the indicator points to the position of the stock’s short-term average relative to its long-term measure. A MACD -a reading above the zero line means that the short-term is above the long-term average. This scenario implies that there is an upward momentum. The opposite is true when the MACD falls below the zero-line.

Analysts at Maxim Group assigned GMO a rating of Buy in their intiating review released on May 19. RBC Capital Mkts analysts see the stock as a Underperform, but they also raised the share’s target price from $1 to $1.30 in a flash note released to investors on March 27. RBC Capital Mkts seeing the stock struggling downgraded it from Sector Perform to Underperform on November 10.

The average rating for the GMO equity is 2 and is currently gathering a bullish momentum. Of 1 analysts tracking General Moly, Inc. polled by Reuters, 0 rated GMO as a hold. The remaining 1 analysts were split evenly. However, the split wasn’t equal as a majority (1) rated it as a buy or strong buy. 0 analyst advised investors against buying the stock or to sell if they own any of the stock.